We are live on ! Find out more
AHCO icon

AdaptHealth

142 hedge funds and large institutions have $1.68B invested in AdaptHealth in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $2.46M | Put options by funds: $1.93M

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

4% more funds holding

Funds holding: 137142 (+5)

2.07% more ownership

Funds ownership: 53.1%55.17% (+2.1%)

11% less capital invested

Capital invested by funds: $1.88B → $1.68B (-$198M)

16% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 50

Holders
142
Holders Change
+5
Holders Change %
+3.65%
% of All Funds
2.49%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
30
Increased
42
Reduced
50
Closed
25
Calls
$2.46M
Puts
$1.93M
Net Calls
+$533K
Net Calls Change
+$355K
Name Holding Trade Value Shares
Change
Change in
Stake
OCA
1
OEP Capital Advisors
New York
$322M
DM
2
Deerfield Management
New York
$189M +$18.1M +750,000 +10%
Vanguard Group
3
Vanguard Group
Pennsylvania
$163M +$2.57M +106,276 +2%
BlackRock
4
BlackRock
New York
$123M -$7.88M -326,033 -6%
Viking Global Investors
5
Viking Global Investors
Connecticut
$94.9M +$23.6M +977,601 +32%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$68.4M -$29.5M -1,218,413 -29%
SAM
7
Silvercrest Asset Management
New York
$58.6M -$1.62M -66,865 -3%
RCMNY
8
Rubric Capital Management (New York)
New York
$53.6M +$55.6M +2,300,000 New
SHI
9
SV Health Investors
Massachusetts
$45.2M -$23.5M -970,559 -33%
MC
10
Maverick Capital
Texas
$37.3M +$17.7M +733,333 +84%
State Street
11
State Street
Massachusetts
$36.2M +$183K +7,578 +0.5%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$34.8M -$2.66M -110,206 -7%
AC
13
Armistice Capital
New York
$30.8M +$14.2M +588,000 +80%
Swedbank
14
Swedbank
Sweden
$27.9M
Marshall Wace
15
Marshall Wace
United Kingdom
$23.4M +$24.3M +1,003,445 New
RCAMU
16
Rothschild & Co Asset Management US
Connecticut
$20.6M +$2.08M +86,143 +11%
JP Morgan Chase
17
JP Morgan Chase
New York
$19.1M -$1.43M -59,100 -7%
PCM
18
Palisade Capital Management
New Jersey
$17M +$6.57M +271,525 +59%
Northern Trust
19
Northern Trust
Illinois
$16.7M -$2.19M -90,726 -11%
Amundi
20
Amundi
France
$15.4M +$16M +659,686 New
MWNA
21
Marshall Wace North America
New York
$15.2M +$15.8M +653,598 New
UBS Group
22
UBS Group
Switzerland
$14.4M -$5.16M -213,275 -26%
KCM
23
Kennedy Capital Management
Missouri
$14.4M +$240K +9,945 +2%
Charles Schwab
24
Charles Schwab
California
$14.2M -$322K -13,308 -2%
EA
25
Emerald Advisers
Pennsylvania
$13.1M -$3.03M -125,155 -18%

AHCO Hedge Fund Activity: Q3 2021 in Review

142 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q3 2021, worth a combined $1.68B — down 11% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new AHCO positions and 25 closed out — a net gain of 5 holders — while 42 added to existing stakes and 50 trimmed.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $55.6M. The largest seller was Wellington Management Group, cutting an estimated $29.5M.

  • 142 institutional investors held AdaptHealth (AHCO) as of Q3 2021, up from 137 in Q2 2021.
  • Funds reported $1.68B of AdaptHealth stock for Q3 2021, down 11% quarter-over-quarter.
  • 30 funds opened new AdaptHealth positions in Q3 2021 and 25 closed out, a net change of +5 holders.
  • The largest AdaptHealth buyer in Q3 2021 was Rubric Capital Management (New York), an estimated $55.6M added.
  • The largest AdaptHealth seller in Q3 2021 was Wellington Management Group, an estimated $29.5M sold.

Based on aggregated 13F filings for Q3 2021.